The cell-mediated immune response plays a critical role in antiviral immunity, and developing early and robust CD8+ and in particular, CD4+ T cell responses correlates well with positive outcomes during SARS-CoV infection (108, 109). This evidence concerns the gene CD8A and severe acute respiratory syndrome.